Human DPPA4 activation kit by CRISPRa

CAT#: GA110609

DPPA4 CRISPRa kit - CRISPR gene activation of human developmental pluripotency associated 4



  See Other Versions

CNY 12,255.00


货期*
4周

规格
    • 1 kit

Product images

经常一起买 (3)
DPPA4 mouse monoclonal antibody, clone OTI1C3 (formerly 1C3)
    • 100 ul

CNY 1,999.00
CNY 2,700.00


DPPA4 (Myc-DDK-tagged)-Human developmental pluripotency associated 4 (DPPA4)
    • 10 ug

CNY 2,400.00
CNY 3,990.00


DPPA4 mouse monoclonal antibody, clone OTI1E12 (formerly 1E12)
    • 30 ul

CNY 800.00

Specifications

Product Data
Format 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug)
Symbol DPPA4
Locus ID 55211
Kit Components

GA110609G1, DPPA4 gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA110609G2, DPPA4 gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA110609G3, DPPA4 gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Disclaimer These products are manufactured and supplied by OriGene under license from ERS. The kit is designed based on the best knowledge of CRISPRa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc.
Reference Data
RefSeq NM_018189, NM_001348928, NM_001348929
Synonyms 2410091M23Rik
Summary This gene encodes a nuclear factor that is involved in the maintenance of pluripotency in stem cells and essential for embryogenesis. The encoded protein has a scaffold-attachment factor A/B, acinus and PIAS (SAP) domain that binds DNA and is thought to modify chromatin. Mice with a homozygous knockout of the orthologous gene die during late embryonic development or within hours after birth. Knockout embryos are normal in size at embryonic day 18.5 but exhibit skeletal and lung tissue abnormalities. This gene, when mutated, is highly expressed in embryonal carcinomas, pluripotent germ cell tumors, and other cancers and is thought to play an important role in tumor progression. Multiple pseudogenes of this gene have been identified. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2017]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Other Versions

Customer Reviews 
Loading...